-
Insights Offered by Advanced Signal Processing Analysis of High-Density EEG of Term Low-risk Newborns
Dr. RB GovindanDone
-
Brain maturation in children with autism spectrum disorder – overly rapid followed by too slow
J. Christopher Edgar, PhDDone
-
High-Intensity Targeted HD-tDCS for Motor Skill Learning
Gavin HsuDone
-
Personalized therapeutic brain-stimulation with real-time EEG-synchronized TMS
Christoph Zrenner, MDDone
-
How to use biomarkers in closed-loop neuromodulation
Marom Bikson, PhDDone
-
Magnetoencephalography (MEG): Considerations vs. EEG for Clinical and Research Applications – A Moving Target?
Timothy P.L. RobertsDone
-
Clinical Applications of EEG in Children
Sudha Kilaru Kessler, MD, MSCEDone
-
Precision in TMS motor mapping and neuromodulation targeting: Clinical relevance and updates
Dylan Edwards, PhDDone
-
Optimizing TMS Targeting and Treatment Response in Depression: Insights from Functional Connectivity and Induced Brain Activity Effects
Romain Duprat, PhDDone
-
A near real-time computational engine for estimating TMS-induced electric fields with applications to mapping and beyond
Evgenii Kim, PhDDone
I am an early career research faculty member at the Lifespan Brain Institute at Children’s Hospital of Philadelphia (CHOP) and University of Pennsylvania (Penn). My lab bridges the areas of developmental psychology and cognitive neuroscience, using multiple levels of analyses (i.e., behavior, EEG, fMRI), to examine how a child’s complex exposome – the confluence of exposures and characteristics – increases or prevents risk for psychopathology, focusing on anxiety. The goal of my lab is to characterize how early exposures (i.e., perinatal depression, early life stress) and individual characteristics (e.g., threat sensitivity, executive function) shape the development of psychopathology risk in young children.
I completed my graduate training with Dr. Nathan Fox at the University of Maryland and my postdoctoral training with Dr. Daniel Pine at NIMH. Currently, I am one of the lead researchers in the CHOP-Penn Lifespan Brain Institute (LiBI) and its Intergenerational Exposome Program (IGNITE).